Physician profile
Eoin Moriarty
NPI 1740897024
$2,312.32
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,367 · 2022: $945.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $506.71 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $405.67 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $333.94 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $248.88 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $218.57 | 2021-2022 | |
| Glaxosmithkline, LLC. | $164.06 | 2021-2022 | |
| Lilly USA, LLC | $104.25 | 2021-2022 | |
| Mylan Specialty L.P. | $97.71 | 2021-2022 | |
| Amgen INC. | $76.08 | 2021-2022 | |
| Pfizer INC. | $71.51 | 2021 | |
| Acerus Pharmaceuticals Corporation | $28.02 | 2022 | |
| Alexion Pharmaceuticals, INC. | $26.02 | 2021 | |
| Bardy Diagnostics, INC. | $17.27 | 2021 | |
| Novo Nordisk INC | $13.63 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eoin Moriarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.